UN backed group sub-licence drug
Pfizer has agreed to allow companies to make a generic version of its Covid treatment pill.
Data from the company says it reduces the risk of hospitalisation by 89 per cent.
The licensing agreement with the Medicines Patent Pool was announced today, and allows the UN backed group to issue sub-licences.
The drug will be administered alongside Ritanovir, which is widely used to treat HIV.

Taoiseach And Ministers To Travel To New York For UN General Assembly
Google Fined €403M Over Handling Of Location Data
Occupied Territories Bill Comes Into Effect
Revolut Scammed After Passing On Data To "Unauthorised Third Party"
"Westminster's Time Is Coming To An End": SF, SNP, And Plaid Cyrmu Call On British Government For Constitutional Change
Man With Kildare Roots To Be Remembered At 9/11 Commemorations In New York Today
Russian Ambassador Says Irish Government "Cannot Be Treated As A Friendly One"
Trump Expected To Visit President Connolly Next Week